Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Outset Medical (OM) EBIAT (2019 - 2025)

Outset Medical (OM) has disclosed EBIAT for 7 consecutive years, with -$19.5 million as the latest value for Q4 2025.

  • Quarterly EBIAT rose 23.98% to -$19.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$81.7 million through Dec 2025, up 36.2% year-over-year, with the annual reading at -$81.7 million for FY2025, 36.2% up from the prior year.
  • EBIAT for Q4 2025 was -$19.5 million at Outset Medical, down from -$17.8 million in the prior quarter.
  • The five-year high for EBIAT was -$17.8 million in Q3 2025, with the low at -$46.2 million in Q3 2023.
  • Average EBIAT over 5 years is -$33.9 million, with a median of -$35.7 million recorded in 2022.
  • The sharpest move saw EBIAT plummeted 45.4% in 2021, then surged 46.19% in 2025.
  • Over 5 years, EBIAT stood at -$41.2 million in 2021, then fell by 0.63% to -$41.5 million in 2022, then increased by 6.9% to -$38.6 million in 2023, then surged by 33.58% to -$25.6 million in 2024, then rose by 23.98% to -$19.5 million in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at -$19.5 million, -$17.8 million, and -$18.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.